# Gephyrin

**Gephyrin** is a multifunctional 93-kDa protein that serves as the core scaffolding protein of inhibitory synapses in the vertebrate central nervous system and, in non-neuronal tissues, catalyzes steps in the biosynthesis of the molybdenum cofactor. It was originally purified in 1982 by [Heinrich Betz](https://www.edgepedia.org/heinrich-betz)'s group as a protein associated with glycine receptors that copurified with polymerized tubulin, and it is now regarded as the anchoring element for glycine and GABA\(_A\) receptors at virtually all inhibitory postsynaptic sites.<sup>[1](https://www.nature.com/articles/emm20155)</sup><sup> • </sup><sup>[2](https://pubmed.ncbi.nlm.nih.gov/30264265/)</sup>

| Key fact | Detail |
|---|---|
| Protein size and discovery | 93-kDa protein purified in 1982 in association with glycine receptors and polymerized tubulin<sup>[1](https://www.nature.com/articles/emm20155)</sup> |
| Domain structure | N-terminal G domain, central C domain (linker), C-terminal E domain; G and E domains are homologous to the bacterial molybdenum cofactor enzymes MogA and MoeA<sup>[1](https://www.nature.com/articles/emm20155)</sup> |
| Synaptic role | Self-assembles into a flat submembranous lattice that slows lateral mobility of glycine and GABA\(_A\) receptors, allowing their clustering at postsynaptic sites<sup>[2](https://pubmed.ncbi.nlm.nih.gov/30264265/)</sup> |
| Metabolic role | Facilitates two steps in molybdenum cofactor biosynthesis; recombinant gephyrin reconstitutes the pathway in Moco-deficient bacteria, mouse cells, and plants<sup>[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC15463/)</sup> |
| Synapse numbers | Purely GABAergic synapses hold ~40–500 gephyrin molecules and 30–200 GABA\(_A\) receptors; spinal cord synapses show twofold higher gephyrin packing density<sup>[1](https://www.nature.com/articles/emm20155)</sup> |
| Key interactors | GlyR β-subunit loop, collybistin, neuroligin 2, dynein light chains 1 and 2, profilin, GABARAP<sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)</sup> |
| Knockout phenotype | Gephyrin knockout mice lack synaptic glycine receptor clustering and show symptoms akin to molybdenum cofactor deficiency<sup>[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC11434336/)</sup> |

## Structure and domains

Gephyrin is organized into three major domains: an N-terminal G domain, a central C domain (linker), and a C-terminal E domain.<sup>[1](https://www.nature.com/articles/emm20155)</sup> The G and E domains correspond structurally to the [Escherichia coli](https://www.edgepedia.org/escherichia-coli) enzymes MogA and MoeA, both involved in [molybdenum cofactor biosynthesis](https://www.edgepedia.org/molybdenum-cofactor-biosynthesis), a homology that revealed the protein's second, metabolic function.<sup>[1](https://www.nature.com/articles/emm20155)</sup> In gephyrin the domain order is reversed relative to the plant Mo-insertase Cnx1, with the G domain at the [N-terminus](https://www.edgepedia.org/n-terminus), and gephyrin carries a much longer linker between its E and G domains (134 versus 11 amino acids in Cnx1).<sup>[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC11434336/)</sup>

Oligomerization underlies scaffold formation: trimerization of G domains and dimerization of E domains are thought to generate multimeric, hexagonal aggregates positioned beneath the plasma membrane.<sup>[1](https://www.nature.com/articles/emm20155)</sup> The full-length protein structure has not been solved, in part because properties of the C domain complicate crystallization.<sup>[1](https://www.nature.com/articles/emm20155)</sup> Recent cryo-EM work showed that gephyrin can form flexible filaments in which dimerized E domains are connected through their subdomain II; variants lacking this subregion, including known pathogenic point mutants, lose filament formation, fail to undergo liquid–liquid phase separation in vitro, and are deficient in synapse formation in vivo.<sup>[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12441120/)</sup>

## Role at inhibitory synapses

At inhibitory synapses gephyrin is the main scaffold anchoring glycine and GABA\(_A\) receptors to the subsynaptic cytoskeleton, in apposition to presynaptic release sites.<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC7351109/)</sup> It self-assembles into a flat submembranous lattice that slows the lateral mobility of these receptors, allowing their clustering; because gephyrin is the core scaffold for virtually all inhibitory synapses, changes in the stability of its lattice alter the packing density of inhibitory receptors and thereby inhibitory drive.<sup>[2](https://pubmed.ncbi.nlm.nih.gov/30264265/)</sup> Single-molecule imaging of glycine receptors in the neuronal membrane found that gephyrin scaffolds act as shallow energy traps of roughly 3 k\(_B\)T, with a depth set by the biochemical properties of the receptor–gephyrin interaction loop.<sup>[8](https://arxiv.org/abs/1502.07044)</sup>

Quantitative nanoscopy has measured the contents of individual synapses. Purely GABAergic synapses contain about 40–500 gephyrin molecules and 30–200 GABA\(_A\) receptors organized in microclusters, while spinal cord synapses, which hold both glycine and GABA\(_A\) receptors, show a twofold higher gephyrin packing density.<sup>[1](https://www.nature.com/articles/emm20155)</sup>

**Receptor binding.** The cytoplasmic loop of the glycine receptor β-subunit binds the gephyrin [E domain](https://www.edgepedia.org/e-domain), with biphasic kinetics spanning dissociation constants from the low nanomolar to low micromolar range.<sup>[6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12441120/)</sup> A serine within this binding motif is phosphorylated and controls binding affinity.<sup>[1](https://www.nature.com/articles/emm20155)</sup> For GABA\(_A\) receptors, a 10-amino-acid hydrophobic motif in the intracellular domain of the α2 subunit binds gephyrin directly, and motifs in the α1 and α3 subunits also bind the E domain; some gephyrin residues key to α2 and α3 binding also contribute to GlyR binding with different affinities.<sup>[1](https://www.nature.com/articles/emm20155)</sup> Not all GABA\(_A\) receptor subtypes depend on gephyrin: cerebellar α2-containing receptors use the dystrophin–dystroglycan complex instead, indicating gephyrin-independent clustering mechanisms for selected subtypes.<sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)</sup>

## Clustering and trafficking

**Collybistin and neuroligin 2.** Collybistin, a brain-specific guanine nucleotide exchange factor, binds gephyrin and is required for postsynaptic gephyrin clustering at GABAergic synapses.<sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)</sup> The adhesion molecule neuroligin 2 binds collybistin and acts as its specific activator, guiding membrane tethering of the gephyrin scaffold to inhibitory postsynaptic sites.<sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)</sup> Collybistin's SH3 domain autoinhibits its PH-domain lipid binding and gephyrin-clustering activity; this inhibition is relieved by neuroligins 2 and 4, the GABA\(_A\) receptor α2 subunit, or the small GTPase TC10, triggering a phospholipid affinity switch from PI3P on endosomes toward plasma-membrane phosphoinositides such as PIP\(_2\) and PIP\(_3\).<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC12032442/)</sup>

Collybistin's role is region-specific. Collybistin knockout mice lose postsynaptic gephyrin and GABA\(_A\) receptor clusters in the hippocampus and basolateral amygdala, but gephyrin puncta are unchanged in neocortex, striatum, medial thalamic areas, brainstem, and spinal cord, showing that collybistin-independent clustering mechanisms also exist.<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC12032442/)</sup> Collybistin-deficient mice show no deficits in glycinergic transmission, so collybistin is dispensable for gephyrin-mediated glycine receptor clustering but required for clustering of certain GABA\(_A\) receptors.<sup>[1](https://www.nature.com/articles/emm20155)</sup>

**Intracellular transport.** Gephyrin interacts with the microtubule-associated motor proteins KIF5 and the dynein light chains Dlc-1 and Dlc-2, supporting active intracellular transport of gephyrin along microtubules.<sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)</sup> Exon 14 of the murine gephyrin gene encodes a 14-amino-acid sequence 80 and 60 percent identical to microtubule-binding repeat motifs of MAP2 and tau, suggesting gephyrin trimers may bind microtubules directly.<sup>[4](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)</sup>

## Regulation of the scaffold

The lattice is dynamically regulated by posttranslational modifications and binding partners.<sup>[2](https://pubmed.ncbi.nlm.nih.gov/30264265/)</sup> [Mass spectrometry](https://www.edgepedia.org/mass-spectrometry) of rat and mouse brains identified 22 phosphorylation sites, mostly in the C domain; serine 268 is phosphorylated by ERK1/2 and serine 270 by GSK-3β through a collybistin-dependent, Cdk5-mediated pathway.<sup>[1](https://www.nature.com/articles/emm20155)</sup> [Lithium chloride](https://www.edgepedia.org/lithium-chloride), a GSK-3β inhibitor, enhances gephyrin clustering in cultured neurons, and it has been speculated that lithium's mood-stabilizing effect may act partly through this mechanism.<sup>[1](https://www.nature.com/articles/emm20155)</sup>

Gephyrin is also palmitoylated at cysteine 212 and cysteine 284 by the Golgi-localized enzyme DHHC-12; this modification, regulated by GABA\(_A\) receptor activity, is essential for postsynaptic membrane association and clustering and increases inhibitory synaptic transmission.<sup>[1](https://www.nature.com/articles/emm20155)</sup> The GPHN gene is alternatively spliced in all three domains, generating variants with different receptor-binding and oligomeric properties; the C4d cassette (exon 11), for example, abolishes glycine receptor binding when present.<sup>[1](https://www.nature.com/articles/emm20155)</sup>

Translational control adds another layer. The microRNA miR153 suppresses translation of Gphn mRNA; during inhibitory long-term potentiation, calcineurin signaling downregulates miR153, lifting this repression and driving de novo gephyrin synthesis and synaptic clustering that underlie synapse potentiation.<sup>[10](https://link.springer.com/article/10.1038/s44319-024-00253-z)</sup>

## Molybdenum cofactor biosynthesis

Independently of its synaptic role, gephyrin facilitates two steps in the biosynthesis of the molybdenum cofactor (Moco), a conserved pterin compound complexing molybdenum that is required for all molybdenum enzymes except nitrogenase.<sup>[2](https://pubmed.ncbi.nlm.nih.gov/30264265/)</sup><sup> • </sup><sup>[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC15463/)</sup> Gephyrin binds [molybdopterin](https://www.edgepedia.org/molybdopterin), the metabolic precursor of Moco, with high affinity, and its expression reconstitutes Moco biosynthesis in Moco-deficient bacteria, a molybdenum-dependent mouse cell line, and a Moco-deficient plant mutant; antisense inhibition of gephyrin expression significantly reduces Moco content in cultured murine cells.<sup>[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC15463/)</sup> Gephyrin is the only known mammalian homolog of the bacterial MogA and MoeA proteins, and its enzymatic and cytosolic aggregation functions were found to be independent.<sup>[3](https://pmc.ncbi.nlm.nih.gov/articles/PMC15463/)</sup><sup> • </sup><sup>[1](https://www.nature.com/articles/emm20155)</sup> The dual function is visible in vivo: gephyrin knockout mice lack synaptic glycine receptor clustering and show symptoms akin to Moco deficiency.<sup>[5](https://pmc.ncbi.nlm.nih.gov/articles/PMC11434336/)</sup>

## Disease links

Because inhibitory transmission is central to brain function, gephyrin dysfunction has been connected to neurological and neuropsychiatric conditions, with reviews discussing implications for Alzheimer's disease and epilepsy.<sup>[2](https://pubmed.ncbi.nlm.nih.gov/30264265/)</sup> A glycine 55 to alanine mutation in the collybistin [SH3 domain](https://www.edgepedia.org/sh3-domain), which disrupts collybistin's dendritic trafficking and association with gephyrin, has been linked to hyperekplexia and epilepsy.<sup>[1](https://www.nature.com/articles/emm20155)</sup> Abnormal GABAergic transmission during development, possibly linked to impaired gephyrin regulation, has been proposed to contribute to the pathophysiology of major neurological and neuropsychiatric diseases.<sup>[11](https://doi.org/10.1038/NRN3670)</sup>

## References

1. [Choii G, Ko J (2015). Gephyrin: a central GABAergic synapse organizer. Experimental & Molecular Medicine 47:e158.](https://www.nature.com/articles/emm20155)
2. [Gephyrin: a key regulatory protein of inhibitory synapses and beyond (review abstract), PubMed.](https://pubmed.ncbi.nlm.nih.gov/30264265/)
3. [Stallmeyer B and colleagues. The neurotransmitter receptor-anchoring protein gephyrin reconstitutes molybdenum cofactor biosynthesis in bacteria, plants, and mammalian cells. PNAS (PMC).](https://pmc.ncbi.nlm.nih.gov/articles/PMC15463/)
4. [The Role of Collybistin in Gephyrin Clustering at Inhibitory Synapses: Facts and Open Questions (PMC).](https://pmc.ncbi.nlm.nih.gov/articles/PMC3125517/)
5. [The Final Step in Molybdenum Cofactor Biosynthesis—A Historical View (PMC).](https://pmc.ncbi.nlm.nih.gov/articles/PMC11434336/)
6. [Gephyrin filaments represent the molecular basis of inhibitory postsynaptic densities (PMC).](https://pmc.ncbi.nlm.nih.gov/articles/PMC12441120/)
7. [Tuning GABAergic Inhibition: Gephyrin Molecular Organization and Functions (PMC).](https://pmc.ncbi.nlm.nih.gov/articles/PMC7351109/)
8. [Mapping the energy and diffusion landscapes of membrane proteins at the cell surface (arXiv).](https://arxiv.org/abs/1502.07044)
9. [Milestone Review: Unlocking the Proteomics of Glycine Receptor Complexes (PMC).](https://pmc.ncbi.nlm.nih.gov/articles/PMC12032442/)
10. [miRNA-mediated control of gephyrin synthesis drives sustained inhibitory synaptic plasticity. EMBO Reports (2024).](https://link.springer.com/article/10.1038/s44319-024-00253-z)
11. [Tyagarajan SK, Fritschy J-M (2014). Gephyrin: a master regulator of neuronal function? Nature Reviews Neuroscience 15:141–156.](https://doi.org/10.1038/NRN3670)

---
*Topic: Encyclopedia › Life and health › Biological foundations › Biochemistry and metabolism › Metabolism and metabolic pathways › Elemental and cofactor metabolism › Cofactor and coenzyme biosynthesis › Metallocofactor assembly › Molybdenum cofactor synthesis*

*Initially written Sep 17, 2026 · Reviewed: Oct 21, 2026 · Edited: Oct 15, 2026; Oct 21, 2026 · Last review: Oct 21, 2026*

*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*

License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license
